TGL WHAAAAAAAT! Alerts, thoughts, discussion. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : TGL WHAAAAAAAT! Alerts, thoughts, discussion.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jim Bishop who wrote (49651)	6/5/2000 11:40:00 AM
From: TallTrader	Read Replies (2) of 150070

IGNE: .105x.11, biotech, creeping up, Level 2 has been creeping up, has a good chart, low float, Bios have been getting press today. IGENE Biotechnology, Inc. Ticker: IGNE Page 1 of 10 Complete Financials: December 1999 Exchange OTC FY END DEC ISSUE DATA (06/02/00) PER SHARE DATA RATIOS Price $ 0.09 EPS (TTM) $ -0.08 P/E (TTM) NM 52W High $ 0.64 Div. Rate $ 0.00 Yield 0.00 % 52W Low $ 0.03 Book Value $ -0.15 Price/Book NM Shrs Out 48.10 Mil Cash $ 0.01 ROE (TTM) NM % Float 5.30 Mil Rev (TTM) $ 0.00 ROA (TTM) -128.42 % Mon. Vol 6.82 Mil Curr. Ratio 4.88 Beta -2.79 LT Dbt/Eqty NM BRIEF: IGENE Biotechnology, Inc. develops, manufactures and markets biochemical products, derived from renewable agricultural residues and wastes. For the FY ended 12/31/99, sales fell 91% to $18K. Net loss increased 1% to $2.5M. Revenues reflect reduced sales of AstaXin due to lower sales to a single large distributor. Loss was partially offset by lower research and development costs and lower compensation costs due to the absence of a CEO.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next